- Home
- DTI vs PRLD Comparison
DTI vs PRLD Comparison
Compare DTI & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTI
- PRLD
- Stock Information
- Founded
- DTI 1984
- PRLD 2016
- Country
- DTI United States
- PRLD United States
- Employees
- DTI N/A
- PRLD N/A
- Industry
- DTI Metal Fabrications
- PRLD Medicinal Chemicals and Botanical Products
- Sector
- DTI Industrials
- PRLD Health Care
- Exchange
- DTI Nasdaq
- PRLD Nasdaq
- Market Cap
- DTI 82.6M
- PRLD 69.1M
- IPO Year
- DTI N/A
- PRLD 2020
- Fundamental
- Price
- DTI $2.52
- PRLD $1.61
- Analyst Decision
- DTI Strong Buy
- PRLD Strong Buy
- Analyst Count
- DTI 1
- PRLD 3
- Target Price
- DTI $5.50
- PRLD $4.00
- AVG Volume (30 Days)
- DTI 43.2K
- PRLD 334.5K
- Earning Date
- DTI 11-06-2025
- PRLD 11-10-2025
- Dividend Yield
- DTI N/A
- PRLD N/A
- EPS Growth
- DTI N/A
- PRLD N/A
- EPS
- DTI N/A
- PRLD N/A
- Revenue
- DTI $162,240,000.00
- PRLD $7,000,000.00
- Revenue This Year
- DTI $0.13
- PRLD N/A
- Revenue Next Year
- DTI $1.58
- PRLD N/A
- P/E Ratio
- DTI N/A
- PRLD N/A
- Revenue Growth
- DTI 9.74
- PRLD N/A
- 52 Week Low
- DTI $1.43
- PRLD $0.61
- 52 Week High
- DTI $3.82
- PRLD $1.91
- Technical
- Relative Strength Index (RSI)
- DTI 61.63
- PRLD 61.89
- Support Level
- DTI $2.15
- PRLD $1.16
- Resistance Level
- DTI $2.30
- PRLD $1.68
- Average True Range (ATR)
- DTI 0.14
- PRLD 0.16
- MACD
- DTI 0.02
- PRLD 0.02
- Stochastic Oscillator
- DTI 82.14
- PRLD 85.85
About DTI Drilling Tools International Corporation
Drilling Tools International Corp manufactures, rents, inspects, and refurbishes downhole drilling tools primarily to companies in the oil and natural gas industry for bottom hole assemblies used in onshore and offshore horizontal and directional drilling. The company's United States operations have locations in Texas, California, Louisiana, Oklahoma, Pennsylvania, North Dakota, New Mexico, Utah, and Wyoming. The company's single segment derives revenues from customers by providing oilfield equipment and services to operators in the oil and natural gas sectors.
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.